UK – Consultation on proposals for changes to the Medicines and Healthcare products Regulatory Agency’s statutory fees (Cell and Gene Therapy Catapult – Regulatory Round-up – August 2022)
The aim of this consultation is to seek the views of stakeholders on proposals to amend statutory fees from the Medicines and Healthcare products Regulatory Agency (MHRA).
The consultation will run from Wednesday 31 August 2022 and close on Wednesday 23 November 2022. The proposed implementation date for these changes is 1 April 2023.
See all of Catapult’s Regulatory Round-up for August 2022 here.
Published on the 1st of September 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (26 octobre 2022). UK – Consultation on proposals for changes to the Medicines and Healthcare products Regulatory Agency’s statutory fees (Cell and Gene Therapy Catapult – Regulatory Round-up – August 2022). ELSIBI. Consulté le 16 janvier 2025 à l’adresse https://doi.org/10.58079/o63p
